Clinical trial
Catheter-based Renal Sympathetic Nerve Ablation for Treatment-resistant Hypertension in Patients With Chronic Kidney Disease
NCT01747382 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Catheter-based Renal Sympathetic Nerve Ablation for Treatment-resistant Hypertension in Patients With Chronic Kidney Disease
- Lead sponsor
- Singapore General Hospital
- Phase
- Expanded access
- Overall status
- No longer available
- Start date
- April 30, 2012
- Completion date
- September 30, 2017
- Enrollment
- Not reported
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease, hypertension